Wound Care Market Research: Current Trends, Opportunities & Global Industry Challenges by 2026


Wound care market has witnessed various technological advancements and emerged as a standard solution to treat acute and chronic wounds. Conventional measures of wound care management are being rapidly replaced with advanced wound measure products due to the effectiveness of the latter for managing wounds, which enables faster healing. The treatment in advanced wound care includes intervention therapies and use of products such as antimicrobial dressings, collagen products, foam dressings, hydrocolloids, gauze, hydrogels, film dressings and alginate dressings. Various chronic wound conditions such as arterial ulcers, diabetic ulcers and venous ulcers can compromise the body’s restorative capabilities. The unhealed wounds do not only diminish quality of life but also increases the risk of infections and complications. Therefore, wound care is an important part of surgical recovery or disease management and is a growing medical specialty.


The research and development is growing at a faster pace in wound care market. For instance, DEBRA International in 2017 started a clinical research program, wound healing in Epidermolysis Bullosa, to develop the understanding, the causes and consequences of non-healing wounds. Also different research activities were undertaken by World Union of Wound Healing Societies in 2016 for the development of biomaterials to be used on acute and chronic wounds. Other factors favoring the market growth include increase in acute and chronic conditions such as diabetic foot ulcers, venous ulcers and pressure ulcers. According to Centers for Disease Control & Prevention, diabetes affects 23.6 million people or 7.8 percent of the population in the U.S., and one-third of all diabetics suffered from lower extremity wounds in 2016. These wounds increase the likelihood of foot problems and the potential for amputation. The packaging trends of advanced wound care products also adds to the increased demand in home care settings as people are able to use them without much medical assistance. For instance, V.A.C. VERAFLO Dressings by KCI Licensing are provided with sterile barrier by using extruded multilayers of nylon.

Wound care market taxonomy:
On the basis of type of wound,
Acute Wound Care
Chronic Wound Care
On the basis of product type,
Advanced Wound Management Products
Surgical Wound Care Products
Traditional/Basic Wound Care Products
On the basis of end user,
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care settings

Asia Pacific emerging as a key market
By geography, North America dominates the market because of the large patient pool for chronic wounds and rapid adoption of new products. According to the National Center for Health Statistics, over US $13 billion was spent on pressure ulcer management in the U.S.in 2015. Moreover, CDC and National Institutes of Health (NIH) estimated that as of 2015, in the U.S. alone approximately 2.5 million pressure ulcers were cured in medical centers. Further Asia Pacific region is ruling out the market. For instance, in January 2016 a distribution agreement was signed between Avita Medical and INDEE Medical for the distribution of its ReCell device in Japan. Also in 2012, Smith & Nephew launched 23 new wound care products in Asian and Chinese markets. Further in the same year, ConvaTec started some operations in India to up bring novel healthcare technologies and treatment measures in Asian market.

Mergers and Acquisitions strengthening the wound care market:
Some of the key players in wound care market are 3M, Coloplast A/S, Baxter International, Inc., Convatec Healthcare B.S.A.R.L, Derma Sciences, Inc., Ethicon, Inc., Hollister, Inc, Mölnlycke Health Care, Smith & Nephew plc, Covidien PLC, Acelity L.P, Kinetic Concept, Inc, Medline Industries, Inc, Integra Lifesciences Corporation, Organogenesis Inc and MPM Medical, Inc. SCA acquired BSN medical in 2015. In July 2014 Clayton, Dubilier & Rice acquired Healogics, the nation's largest provider of advanced wound care services with nearly 600 hospital outpatient wound care centers. The acquisition of Healthpoint, Ltd in 2012 provided Smith & Nephew plc with an opportunity to strengthen its position in the market. The acquisition of Covidien, the second largest player in wound care market by Medtronichelped the company to strengthen its product portfolio in wound care. The acquisition of Dermagraft Assets from Shire's Regenerative Medicine in 2014 by Organogenesis strengthens the position pf the acquirer in the chronic wound care market.

For a proper wound care management a major focus is laid on understanding the characteristics of the wound and assessment depends on following factors:
The size and depth of involvement and the extent of undermining required
The appearance of the wound surface, whether it is necrotic or viable
The amount and characteristics of wound exudate
The condition of the periwound tissues depending on whether they are scarred, pigmented, atrophic and cellulitic.

Click To Read More On Wound Care Market

Comments

Post a Comment

Popular posts from this blog

Medical Automation Market Analysis, Growth, Size, Share, Trends, Supply Demand and Forecast to 2026

Medical automation is a technology used to minimize medical errors, promote better management of chronic illness, and to enable healthcare professionals to anticipate prognosis. It controls the diagnostic, monitoring, and therapeutic machineries that serves the major responsive tasks into the hospitals. It also increases the predictability of outcome when patients follow a standardized care path supported by automation. Moreover, automation can help to detect when a patient has deviated from recommended care plan so the care team can intervene. The technology implementation enhances efficiency of hospitals by reducing the process time and improving accuracy of a medical procedures. Medical automation in hospitals such as using robotic assisted systems for health check-ups, is also propelling the growth of the market and in turn improving patient safety. Hospitals are adopting the medical robotics to reduce the HAIs rates in healthcare facility and to provide cleaner and saf...
Read more

Medical Disposables Market to Witness a Pronounce Growth by 2026

Medical disposables are products that are used in hospitals or in various medical fields for prevention of infections and for safety measures to meet the medical standards. The medical disposables are important to lower the risk of cross-contamination and infections that is a primary aim of healthcare professionals and governments globally. Medical disposables includes conventional syringes, disposable medical catheters, isolation gowns, procedure kits and trays, blood glucose tes t strips, and wound care products. The medical disposables are the essential component of every hospital and they have one time usage and need to be disposed after use. Medical disposables are used in surgery, drug and fluid delivery, wound management, diagnostic testing, patient examination, incontinence management, sterilization, and to reduce the discomfort of patient. The need of safety and prevention from infections for the various medical fields such as surgical wear, hygiene, anesthesia and ped...
Read more

Cancer Vaccines Market Taking New Steps to Meet the Challenges With Major Key Companies

Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes. On the basis of the type of cell it initiates to form cancerous with, it is divided into carcinoma, lymphomas, leukaemias, brain tumors, and sarcomas. According to World Health Organization (WHO), 2017, nearly 1 in 6 deaths is due to cancer globally and around 70% of deaths from cancer occur in low- and middle-income countries. Moreover, it is projected that for next two decades, 70% of new cases are expected to be diagnosed globally. Advent of cancer vaccines can significantly reduce this numbers and lead a cancer-free life for the global population. Key players in the global cancer vaccines market include, Astrazeneca Plc. (Medimmune, LLC.), Glaxosmithkline Plc., Merck & Co., Inc., Sanofi Pasteur, Aduro BioTech Inc., Sanpower Group, Astellas Pharma Inc., CSL Limited, Pfizer Inc., and Serum Institute of India Pvt. Ltd. Dow...
Read more